These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

947 related articles for article (PubMed ID: 20176266)

  • 1. Allergen immunotherapy.
    Frew AJ
    J Allergy Clin Immunol; 2010 Feb; 125(2 Suppl 2):S306-13. PubMed ID: 20176266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 25. Immunotherapy of allergic disease.
    Frew AJ
    J Allergy Clin Immunol; 2003 Feb; 111(2 Suppl):S712-9. PubMed ID: 12592316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific immunotherapy in children.
    Bufe A; Roberts G
    Clin Exp Allergy; 2011 Sep; 41(9):1256-62. PubMed ID: 21518041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical efficacy and costs of the three-year specific allergen immunotherapy--retrospective study].
    Targowski T; Jahnz-Rózyk K; Przekora P; Kucharczyk A; Owczarek W
    Pol Merkur Lekarski; 2011 Aug; 31(182):106-10. PubMed ID: 21936348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
    Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
    J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of subcutaneous allergen immunotherapy.
    Soyer OU; Akdis M; Akdis CA
    Immunol Allergy Clin North Am; 2011 May; 31(2):175-90, vii-viii. PubMed ID: 21530813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological mechanisms of sublingual immunotherapy.
    Akdis CA; Barlan IB; Bahceciler N; Akdis M
    Allergy; 2006; 61 Suppl 81():11-4. PubMed ID: 16792600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublingual immunotherapy mechanisms of action: the role of Th1 response.
    Ciprandi G; Tosca MA; Marseglia GL
    Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):9-12. PubMed ID: 19944003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T regulatory cells in allergen-specific immunotherapy.
    Verhagen J; Taylor A; Blaser K; Akdis M; Akdis CA
    Int Rev Immunol; 2005; 24(5-6):533-48. PubMed ID: 16318994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy: The meta-analyses. What have we Learned?
    Calderón MA; Boyle RJ; Penagos M; Sheikh A
    Immunol Allergy Clin North Am; 2011 May; 31(2):159-73, vii. PubMed ID: 21530812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of allergen specific immunotherapy--T-cell tolerance and more.
    Jutel M; Akdis M; Blaser K; Akdis CA
    Allergy; 2006 Jul; 61(7):796-807. PubMed ID: 16792576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy.
    Pipet A; Botturi K; Pinot D; Vervloet D; Magnan A
    Respir Med; 2009 Jun; 103(6):800-12. PubMed ID: 19216064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune tolerance in allergy.
    Akdis M
    Curr Opin Immunol; 2009 Dec; 21(6):700-7. PubMed ID: 19700272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergen-specific immunotherapy alters the expression of B and T lymphocyte attenuator, a co-inhibitory molecule, in allergic rhinitis.
    Okano M; Otsuki N; Azuma M; Fujiwara T; Kariya S; Sugata Y; Higaki T; Kino K; Tanimoto Y; Okubo K; Nishizaki K
    Clin Exp Allergy; 2008 Dec; 38(12):1891-900. PubMed ID: 19016801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms.
    Crimi N; Li Gotti F; Mangano G; Paolino G; Mastruzzo C; Vancheri C; Lisitano N; Polosa R
    Ann Ital Med Int; 2004; 19(2):98-108. PubMed ID: 15317270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunological overview of allergen specific immunotherapy -- subcutaneous and sublingual routes.
    Ozdemir C
    Ther Adv Respir Dis; 2009 Oct; 3(5):253-62. PubMed ID: 19880430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of allergen-specific immunotherapy (desensitization) for the treatment of allergies in Germany. Current situation].
    Kleine-Tebbe J; Ackermann-Simon J; Hanf G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Mar; 55(3):343-50. PubMed ID: 22373847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The immunological mechanisms contributing to the clinical efficacy of allergen specific immunotherapy (SIT) in allergic diseases].
    Asher I; Mahlab-Guri K; Sthoeger Z
    Harefuah; 2013 Sep; 152(9):529-33, 564, 563. PubMed ID: 24364093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.